Drug Safety Through AI & Computer Vision

The organization is a MedTech company that offers healthcare institutions an integrated and patented hardware and software solution for medication verification at the patient’s bedside. The system visually recognizes individual tablets and capsules, verifies them in real time against the electronic prescribing system, and records the administration in a fully traceable manner, thereby covering all checkpoints—including dosage—in a single step.

Organization
The company maintains its own, continuously updated medication database, validated integrations with common prescribing systems, and medical-technical certification, supported by years of clinical evidence from daily practice. With an installed base in 10 healthcare institutions across 3 countries, the organization generates recurring license and service revenue with high retention: once embedded in the medication process, the switching costs are significant. This results in recurring revenue of 94% of total revenue of approximately €817k (excluding subsidies) (FY2025), with a gross margin of 90%.

Growth Opportunities
The growth potential lies in increasingly stringent requirements regarding registration and traceability, the structural labor shortage that makes time savings in medication rounds directly financially measurable, and the opportunity to expand into long-term care and home care—adjacent segments that are currently underserved. The technology is country-agnostic and can be expanded in each market solely through local database and system integrations, making international rollout proven and scalable.